[
    {
        "type": "text",
        "text": "In vivo targeted magnetic resonance imaging and visualized photodynamic therapy in deep-tissue cancers using folic acid-functionalized superparamagnetic-upconversion nanocompositest ",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Leyong Zeng,ab Lijia Luo,a Yuanwei Pan,a Song Luo,b Guangming $\\mathsf { L u ^ { \\star b , c } }$ and Aiguo Wu\\*a ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Multifunctional nanoprobes used in magnetic resonance imaging (MRl) and photodynamic therapy (PDT) also have potentialapplications indiagnosisand visualized therapyof cancers,and hence it is important to investigate theactive-targetingabilityand invivo reliabilityof these nanoprobes.In this work,folicacid (FA)-targeted,photosensitizer (PS)-loaded $\\mathsf { F e } _ { 3 } \\mathsf { O } _ { 4 } @ { \\mathsf { N a Y F } _ { 4 } } \\mathrm { : Y b / E }$ r (FA-NPs-PS) nanocomposites were synthesized for in vivo $T _ { 2 }$ -weighted MRl and visualized PDT of cancers by modeling MCF-7 tumor-bearing nude mice.By measuring the upconversion luminescence (UCL) and fluorescence emission spectra,the as-prepared FA-NPs-PS nanocomposites showed near-infrared (NIR)-triggered PDT performance due to the production of a singlet oxygen species.Moreover,by tracing PS fluorescence in MCF-7, HeLa cells and in MCF-7tumors,the FA-targeted nanocomposites demonstrated good targeting ability both in vitro and in vivo.Under the irradiation of a $9 8 0 ~ \\mathsf { n m }$ laser, the viabilities of MCF-7 and HeLa cells incubated with FA-NPs-PS nanocomposites could decrease to about $1 8 . 4 \\%$ and $30 . 7 \\%$ ,respectively,and the inhibition of MCF-7 tumors could reach about $9 4 . 9 \\%$ The transverse $M { \\sf R }$ relaxivity of $6 3 . 7 9 \\mathrm { \\ m M ^ { - 1 } \\ s ^ { - 1 } }$ （ $( r _ { 2 }$ value)and in vivo MR imaging of MCF-7 tumors indicated an excellent $T _ { 2 }$ -weighted $M { \\sf R }$ performance. This work demonstrated that FA-targeted MRl/PDT nanoprobesareeffective for in vivo diagnosisand visualized therapy of breast cancers. ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "1.Introduction ",
        "text_level": 1,
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "Multifunctional nanoprobes for magnetic resonance imaging (MRI) and photodynamic therapy (PDT) have shown potential applications in diagnosis and visualized therapy of cancers due to the advantages of being non-radiative and non-invasive. In addition，photosensitizers (PS),as light-driven drugs,also play a key role in the PDT of cancers.Many nanomaterials, such as carbon nanodots，gold nanorods，graphene and upconversion luminescence (UCL） nanomaterials,have been investigated as carriers of PS and have shown to improve the PDT performance as well as the imaging performance.1-4 Moreover,magnetic nanomaterials were also used to load PS for simultaneous MRI and PDT.5-8 In previous reports, multifunctional nanoprobes of MRI/PDT were usually organic PSloaded superparamagnetic/paramagnetic nanomaterials for $T _ { 1 } \\cdot$ 号 or $T _ { 2 }$ weighted MRI and visible-triggered organic $\\mathrm { P D T } ^ { 5 - 1 2 }$ and inorganic PS-loaded superparamagnetic nanomaterials for MRI and visible/ultraviolet (Uv)-triggered inorganic PDT.13,14 ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "At present,the clinical use of PDT is restricted due to its weak penetration into deep tissues and non-specific damage to normal tissues.Itis known that visible/ultraviolet (UV) light (about $4 0 0 { \\mathrm { - } } 7 0 0 \\ \\mathrm { n m }$ ）has weak penetration,only a few millimeters,butnear-infrared (NIR) radiation (about $7 0 0 { - } 1 1 0 0 ~ \\mathrm { n m }$ ） hasdeeppenetration into tissues，by one toseveral centimeters.15-18 The targeting strategy of nanoprobes is critical to improve their selectivity in imaging and therapy of cancers,which could reduce the non-specific damage.19 Folic acid (FA) is one of the most popular targeting ligands as it could have high specificity to breast and cervical tumors,in which the FA receptor is over-expressed.26 By coupling targeting ligands with nanoprobes,the specific uptake of tumors can be increased and the non-specific damage of normal tissues decreased.20-24 Recently,due to the excellent properties of UCL nanomaterials in MRI/fluorescence imaging,25,26 mag netic-upconversion nanocomposites with different structures and performances have been synthesized and widely investigated²7 and are promising as a type of theranostic system for deep-tissue diagnosis,visualized therapy，and also for the prognosis assessment of cancers.24,28-32 The synthesis of PS-loadedGd-basedupconversion nanocomposites, $T _ { 1 }$ -weighted MRI and NIR-triggered PDT,has been previously reported,which demonstrated the simultaneous MRI and deep-tissue PDT in vitro and in vivo.3-37 On considering the good biocompatibility of superparamagnetic iron oxide nanoparticles， superparamagnetic-upconversion nanocomposites havebeen synthesized bya silica-assisted method,and they were also investigated for MRI and fluorescent imaging.29,38-42 However,it was found to be more interesting to design photosensitizer-loadedironoxide-UCLnanocompositesfor $T _ { 2 }$ weighted MRI and NIR-triggered visualized PDT in deeptissue tumors.Furthermore，in vivo biocompatibilityand in vivo reliability of nanoprobes were the basis of clinical applications.Therefore，to improve safety and selectivity，it was important to develop targeted nanoprobes of MRI and NIRtriggered visualized PDT and simultaneously investigate in vivo reliability in deep-tissue cancers. ",
        "page_idx": 0
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "In this study,we report the synthesis of FA-targeted,photo sensitizer (PS)-loaded $\\mathrm { F e _ { 3 } O _ { 4 } @ N a Y F _ { 4 } : Y b / E r }$ (FA-NPs-PS) nano composites via direct coupling and their applications for in vivo targeted $T _ { 2 }$ weighted MRI and visualized PDT in deeptissue cancers.Singlet oxygen was measured,and in vitro PDT was characterized for MCF-7 and HeLa cells under the excitation of a $9 8 0 ~ \\mathrm { n m }$ laser.Moreover,by tracing PS fluorescence, the targeting ability of FA was assessed both in vitro and in vivo.Finally,by modeling MCF-7 tumor-bearing nude mice, in vivo MRI and PDT performance of FA-NPs-PS nanocompo sites were investigated.This work provided new insight for targetingand invivo reliability ofMRI/PDT nanoprobes and will be helpful for developing new theranostic systems in targeted diagnosis and visualized therapy of deep-tissue cancers. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "2．Experimental section ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "2.1 Chemicalsandmaterials ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Ferric acetylacetonate $\\left( \\mathrm { F e } ( \\mathrm { a c a c } ) _ { 3 } \\right)$ ，rare-earth oxides $\\left( \\mathbf { Y } _ { 2 } \\mathbf { O } _ { 3 } \\right.$ $\\mathrm { Y b } _ { 2 } \\mathrm { O } _ { 3 }$ = $\\mathrm { E r } _ { 2 } \\mathrm { O } _ { 3 } \\dot { . }$ ),trifluoroacetic acid $\\left( \\mathbf { C F } _ { 3 } \\mathbf { C O O H } \\right)$ ,sodium carbonate $\\left( \\mathrm { N a } _ { 2 } \\mathrm { C O } _ { 3 } \\right)$ and 3-aminopropyltriethoxysilane (APTS)were purchased from Aladdin Industrial Inc. (Shanghai,China). Oleylamine (OM), $n$ octyl alcohol,polyethylene glycol (PEG, $\\mathbf { M } \\mathbf { W } = 1 5 0 0$ ）and folic acid (FA) were purchased from Sinopharm Chemical Reagents Co.Ltd (Shanghai,China). Tetrasulfonic phthalocyanine aluminium $\\mathrm { ( A l P c S _ { 4 } ) }$ organic photosensitizer and9,10-anthracenediyl-bis(methylene)dimalonic acid (ABDA) were purchased from J&K Scientific Ltd (Shanghai China).5-Diphenyl-2-H-tetrazolium bromide (MTT),1-ethyl-3- 中 $3 ^ { \\prime }$ dimethylaminopropyl) carbodiimide (EDC), $N \\cdot$ hydroxysuccinimide (NHS),Dulbecco's modified Eagle'smedium (DMEM) and fetal bovine serum (FBS,Gibco) were purchased from Keygen Biotech Co. Ltd (Nanjing,China). Calcein acetoxymethyl ester (CAM) and ethidium homodimer-1 (EthD-1) were purchased from Life Technologies (Shanghai, China).All the chemicals were used as received without further purification. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "2.2Synthesis and characterization of nanocomposites ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "$\\mathrm { F e _ { 3 } O _ { 4 } \\mathrm { - N a Y F _ { 4 } \\mathrm { : } Y b } }$ /Ernanoparticles(NPs)， FA-targeted NPs (FA-NPs) and PS-loaded FA-NPs (FA-NPs-PS) were firstly synthesized. The transmission electron microscopy (TEM) images were taken using a Tecnai F2o transmission electron microscope operated at $2 0 0 \\ \\mathrm { k V } .$ The dynamic light scattering (DLS) spectra were obtained using a Brookhaven ZetaPALS Analyzer. The $M { - } H$ curves were measured by Quantum Design Model-9 physical performance measurement system (PPMS). The UVvisabsorption spectra were obtainedby a PerkinElmer Lambda 35 UV-vis spectrophotometer.The fluorescent emission spectra and UCL spectra were measured by a Hitachi F4600 fluorescent spectrophotometer.MR imaging and relaxivityperformance were tested by a $3 . 0 \\mathrm { ~ T ~ }$ clinical MR instrument (Siemens Trio) and Mico MR analyzing system (Shanghai Niumag Corporation) with a magnetic field of 0.47 T,respectively.The cell viabilities in the MTT assay were measured by a BioTek ELX 8oo microplate reader. The live/dead cell staining and the Hematoxylin and Eosin (H&E) staining were examined using a Leica DMI 3ooo fluorescent microscope.The fluorescence imaging of AlPcS4 photosensitizers in cells and in tumors was carried out using a IVIs Lumina animal imaging system (Xenogen Corporation-Caliper, USA). ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "2.3Invitro MRI andPDT ",
        "text_level": 1,
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "For in vitro MRI measurement,MCF-7 and HeLa cells in logarithmic growth were cultured in 6-well plates for $2 4 \\mathrm { ~ h ~ }$ and then were incubated with NP-PS and FA-NPs-PS,in which the concentrations of different nanoparticles were 0,50,1oo,150,200, and $2 5 0 ~ \\mu \\mathrm { g } \\ \\mathrm { m L } ^ { - 1 }$ .After another $2 4 \\mathrm { ~ h ~ }$ ，the MCF-7 and HeLa cells were washed with PBS three times,digested and collected by centrifugation.Finally,they were dispersed in $1 ~ \\mathrm { m L }$ of $1 \\%$ agarose for the $T _ { 1 } \\mathrm { { ^ { - } } }$ and $T _ { 2 }$ -weighted MR imaging in the $3 . 0 \\mathrm { ~ T ~ }$ clinical MR instrument.Furthermore, $T _ { 1 ^ { - } }$ and $T _ { 2 }$ -weighted MR imaging and relaxivity of NP-PS and FA-NPs-PS were also measured, respectively. ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "Forin vitro PDT measurements,MCF-7 and HeLa cells in logarithmic growth were cultured in 96-well plates for $2 4 \\mathrm { ~ h ~ }$ and then were incubated with NPs，FA-NPs,NP-PS,and FA-NPs-PS for another $2 4 \\mathrm { ~ h ~ }$ ，in which the concentrations of different nanoparticles were 0,50,100,150,200,and $2 5 0 ~ \\mu \\mathrm { g }$ $\\mathrm { m } \\mathrm { L } ^ { - 1 }$ .After $^ \\textrm { \\scriptsize 4 h }$ ，the cells were irradiated by a $9 8 0 \\ \\mathrm { n m }$ laser with a power density of $0 . 5 ~ \\mathrm { W ~ c m } ^ { - 2 }$ for 0,1,4,7, and $1 0 ~ \\mathrm { m i n }$ respectively.After another $2 0 \\mathrm { ~ h ~ }$ ，theviabilitieswere measured by the MTT assay.Furthermore,the viabilities of MCF-7 and ",
        "page_idx": 1
    },
    {
        "type": "text",
        "text": "HeLa cells，as control experiments，were measured after irradiation by a $9 8 0 \\mathrm { n m }$ laser. ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "2.4In vivo MRI and PDT ",
        "text_level": 1,
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "For in vivo MRI measurements,MCF-7 tumor-bearing nude micewere intratumorally injected with $1 0 0 ~ \\mu \\mathrm { L }$ of FA-NPs-PS $( 5 0 0 ~ \\mu \\mathrm { g } ~ \\mathrm { m L } ^ { - 1 }$ in PBS)，and the $T _ { 1 } { \\mathrm { : } }$ and $T _ { 2 }$ -weighted MR imaging was measured $^ { 2 \\mathrm { ~ h ~ } }$ before and $^ { 2 \\mathrm { ~ h ~ } }$ after the injection. Furthermore,MCF-7 tumor-bearing nude mice were also injected with $1 0 0 ~  { \\mu \\mathrm { L } }$ of PBS,free PS $( 1 2 . 5 ~ \\mu \\mathrm { g } \\ : \\mathrm { m L } ^ { - 1 }$ in PBS), NPs-PS ( $\\mathrm { 5 0 0 ~ \\mu g ~ m L ^ { - 1 } }$ in PBS),and FA-NPs-PS ( $\\mathrm { 5 0 0 ~ \\mu g ~ m L ^ { - 1 } }$ in PBS) via the tail vein,and then the PS fluorescence imaging of tumor,heart, liver,spleen,lung,and kidney in different mice was undertaken using an animal imaging system. ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "For in vivo PDT measurements,MCF-7 tumor-bearing nude mice were randomly divided into 4 groups( ${ \\mathit { \\Delta } } _ { n } = 6$ ，pergroup). The tumor-bearing nude mice were intratumorally injected and irradiated with $1 0 0 ~  { \\mu \\mathrm { L } }$ Of PBS,PBS $^ +$ NIR，FA-NPs-PS $\\left( 5 0 0 ~ \\mu \\mathrm { g } \\ : \\mathrm { m L } ^ { - 1 } \\right.$ in PBS),FA-NPs-PS $^ +$ NIR $\\mathrm { 5 0 0 ~ \\mu g ~ m L ^ { - 1 } }$ in PBS), for groups 1,2,3,and 4,respectively.In particular, the mice in groups 2 and 4were irradiated by a $9 8 0 ~ \\mathrm { n m }$ laserwitha power density of $0 . 5 ~ \\mathrm { W ~ c m } ^ { - 2 }$ for $1 0 ~ \\mathrm { m i n }$ on the second day after the injection.The tumor volume and body weight were measured everyother day,and the volume was calculated to be length $\\times$ width $\\times$ width/2.On the fifteenth day,the mice were sacrificed, and the tumors and the major organs (heart,liver,spleen, lung，and kidney) were dissected for H&E staining.For the MCF-7 tumor-bearing nude mice in groups 3 and 4,the PS fluorescence imaging was recorded between 15 day treatments. ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "2.5 Statistical analysis ",
        "text_level": 1,
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Datawere expressed as mean $\\pm$ standard deviation (SD).Statistical differenceswere analyzed by the Student's $t$ test.Avalue of $p < 0 . 0 5$ was taken as statistically significant. ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "3．Results and discussion ",
        "text_level": 1,
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "3.1SynthesisandcharacterizationofFA-NPs-PS nanocomposites ",
        "text_level": 1,
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "Fig.1 shows the synthesis schematic of FA-NPs-PS nanocomposites for simultaneous $T _ { 2 }$ -weighted MRI and PDT of breast cancers.The as-prepared core-shell $\\mathrm { F e _ { 3 } O _ { 4 } @ N a Y F _ { 4 } ; Y b / E r }$ nanoparticles were modified with PEG,APTS,FA targeting ligands, and loaded with PS.The obtained FA-NPs-PS nanocomposites were applied as targeted theranostic nanoprobes for in vivo $T _ { 2 }$ -weighted MRI and NIR-triggered PDT of breast cancers under the irradiation of a $9 8 0 ~ \\mathrm { n m }$ laser. ",
        "page_idx": 2
    },
    {
        "type": "text",
        "text": "In order to investigate the application of FA-NPs-PS nanocomposites in MRI and PDT of cancers,the physicochemical properties of different nanoparticles were firstly characterized. Fig.2(a) shows DLS curves of different nanoparticles,in which the average size of NPs,FA-NPs,and FA-NPs-PS was 129,147, and $1 7 5 ~ \\mathrm { { n m } }$ ,respectively,and the inset shows the TEM image of core-shell $\\mathrm { F e _ { 3 } O _ { 4 } @ N a Y F _ { 4 } : Y b / E r }$ nanoparticles.The slight increase of nanocomposite size from NPs,FA-NPs to FA-NPsPS could be attributed to the change of surface potential, which was measured to be $3 7 . 1 ~ \\mathrm { \\ m V }$ ， $1 6 . 8 \\mathrm { \\ m V }$ and $1 2 . 5 \\ \\mathrm { m V } ;$ （2 respectively (Fig. $\\mathbf { S 1 \\dag }$ ).Fig.2(b) shows the UV-vis absorbance spectra of NPs,FA-NPs,and FA-NPs-PS.In the UV-vis spectra ofFA-NPsand FA-NPs-PS,a wide absorbance band located at about $3 8 0 ~ \\mathrm { n m }$ and two absorbance peaks located at about 630 and $6 7 0 ~ \\mathrm { { n m } }$ areobserved,respectively.Based on UV-vis absorbance spectra of free FA and free PS (Fig. $^ { S 2 \\dagger }$ ),the wide band located at $3 8 0 ~ \\mathrm { { n m } }$ could be attributed to FA,and the peaks locatedat630and $6 7 0 ~ \\mathrm { { n m } }$ could be attributed to PS.In the inset of Fig.2(b),the color change of different colloids also indicated that the FA and PS were successfully coupled and loaded.Fig.2(c) shows the $M { - } H$ curves for different nanoparticles,in which the saturation magnetization of NPs, FA-NPs and FA-NPs-PS was 15.6,14.8,and 14.0 emu $\\mathrm { g } ^ { - 1 }$ respectively,and the real images of magnetic separation also demonstrated good magnetism of different nanoparticles. ",
        "page_idx": 2
    },
    {
        "type": "image",
        "img_path": "images/53330b4222f8883e6bf4cc9013060eafbc4ea448251857031aa72e3f59236e77.jpg",
        "img_caption": [
            "Fig.1Schematics of bi-functional theranostic nanoprobes based on FA-targeted photosensitizer-loaded $\\mathsf { F e } _ { 3 } \\mathsf { O } _ { 4 } \\ @ \\mathsf { N a Y F } _ { 4 }$ :Yb/Ernanocomposites. "
        ],
        "img_footnote": [],
        "page_idx": 2
    },
    {
        "type": "image",
        "img_path": "images/4f50a0d4895557b82ac60ba290c531d256a7aaf3065c8b28831445bfff581726.jpg",
        "img_caption": [
            "Fig.2Size distribution, UV-vis absorbance spectra, $M - H$ curves, UCL spectra,and fluorescent spectra of NPs,FA-NPsand FA-NPs-PS nanocomposites.a)DisU shown in the inset; (c) $M - H$ curves,and thecorresponding realimagesofcolloidsare shown in te inset; (d)UCLspectra under the excitationof $9 8 0 ~ \\mathsf { n m }$ laser;(e) fluorescent emission spectra with an excitation wavelength of $6 3 3 \\ \\mathsf { n m } .$ ：(f） singlet oxygen detection of FA-NPs-PS under the irradiation ofa $9 8 0 ~ \\mathsf { n m }$ laser for diferent timesby measuring thefluorescent emission spectraof ABDAwith the excitation wavelength of $3 8 0 ~ \\mathsf { n m }$ "
        ],
        "img_footnote": [],
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "UCL and the production of a singlet oxygen species were both important factors to investigate NIR-triggered PDT of PSloaded UCL nanomaterials.Fig.2(d) shows the UCL spectra of NPs,FA-NPs and FA-NPs-PS under the irradiation of a $9 8 0 ~ \\mathrm { n m }$ laser,in which three main UCL bands located at about 545, 659 and $4 8 8 ~ \\mathrm { { n m } }$ were observed，respectively.Moreover，the fluorescent emission peak located at about $6 7 8 ~ \\mathrm { n m }$ indicated a strong emission of photosensitizers in the FA-NPs-PS sample, as shown in Fig.2(e).By reacting ABDA and FA-NPs-PS under theirradiation of a $9 8 0 \\ \\mathrm { n m }$ laser,the fluorescent emission spectra of ABDA were measured.As shown in Fig.2(f),the peak intensity of ABDA fluorescent emission gradually decreased by increasing the irradiation time from O to $1 5 ~ \\mathrm { m i n }$ which indicated that the singlet oxygen species could be produced under the irradiation of a $9 8 0 \\ \\mathrm { n m }$ laser.However,by reacting ABDA and free PS under the irradiation of a $9 8 0 ~ \\mathrm { n m }$ laser,the peak intensity of ABDA did not decrease,indicating that no singlet oxygen species was produced.The results indicated that the as-prepared FA-NPs-PS nanocomposites could have good PDT performance for cancers. ",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "3.2In vitro and in vivo biocompatibility study ",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "To prove the safety of FA-NPs-PS nanocomposites, the in vitro and in vivo biocompatibility was investigated by the MTT assay and H&E staining,respectively.Fig.3(a) and (b) show the viabilities of MCF-7 and HeLa cells incubated with NPs, FA-NPs,NPs-PS,and FA-NPs-PS with different concentrations. It was observed that the viabilities were higher than $8 8 \\%$ for MCF-7 cells and higher than $8 7 \\%$ for HeLa cells.Moreover,in all nanoparticles,cell viabilities incubated with FA-NPs-PS were the lowest,which could be attributed to the toxicity of PS and the excessive uptake of nanoparticles due to FA targeting. Fig.3(c) shows the H&E staining images of the major organs of healthy nude mice injected with PBS and FA-NPs-PS via the tail vein.No evident tissue lesion was observed in histological specimens of the two experimental groups.The fibrosis of the heart and lungs was not observed, the inflammatory reaction of the liver was not found, the glomerular and tubular in the kidneys were clearly displayed,and the structure of the intestinal villus was clearly present in the intestine.The in vitro and in vivo biocompatibility indicated that the as-prepared FA-NPsPS nanocomposites could be safe for possible applications in MRI and PDT of cancers. ",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "3.3In vitro and in vivo MRI study ",
        "text_level": 1,
        "page_idx": 3
    },
    {
        "type": "text",
        "text": "The in vitro and in vivo MR performances were investigated by measuring the longitudinal and transverse MR relaxivity and the $T _ { 1 } \\cdot$ and $T _ { 2 }$ -weighted MR imaging.Fig.4(a) shows the longitudinal $\\left( { r _ { 1 } } \\right)$ and transverse $\\left( r _ { 2 } \\right)$ relaxivity curves of FA-NPs and FA-NPs-PS,in which the $r _ { 1 }$ and $r _ { 2 }$ values were $1 . 7 4 ~ \\mathrm { m M ^ { - 1 } ~ s ^ { - 1 } }$ $4 8 . 4 2 \\ \\mathrm { m M ^ { - 1 } } \\ \\mathrm { s ^ { - 1 } }$ for FA-NPs and $2 . 0 2 \\ \\mathrm { m M ^ { - 1 } } \\ \\mathrm { s ^ { - 1 } }$ ， $6 3 . 7 9 \\ \\mathrm { m M } ^ { - 1 }$ $ { \\mathbf { s } } ^ { - 1 }$ for FA-NPs-PS.By loading PS,the improvement of the $r _ { 2 }$ value might be related to the better stability of FA-NPs-PS nanocomposites.Moreover,as shown in Fig. $4 ( \\mathrm { b } )$ ，the $T _ { 1 ^ { - } }$ and $T _ { 2 }$ -weighted MR images of the nanoparticles and their incubation cells were also characterized, in which the $T _ { 2 }$ -weighted MR images got darker. Fig. 4(c) and (d) show the in vivo $T _ { 2 }$ -weighted MR images of MCF-7 tumor-bearing nude mouse $^ { 2 \\mathrm { ~ h ~ } }$ before and after the injection,in which the tumor section obviously got darkerafter the injection.The in vitro and invivo MR results demonstrate that the as-prepared FA-NPs-PS nanocomposites could have potential applications as $T _ { 2 }$ -weighted MRI contrast agents. ",
        "page_idx": 3
    },
    {
        "type": "image",
        "img_path": "images/6a69131352b81aa7a1596668a243d971b58cd54434cde423fe3d2b31fee6c2c7.jpg",
        "img_caption": [
            "Fig.IirodiifomidVbiif-elbdi NPs-PS,adF-.(b)bifecbadis-ds-.c)Eaif (heart,liver,spleen,ung,idneyandintestine)fhealthyudemiceinjectedwithPBandFA-NPs-PSviatetailvein. "
        ],
        "img_footnote": [],
        "page_idx": 4
    },
    {
        "type": "image",
        "img_path": "images/409a3a9cfd78844e07508ccd4a94e52b302af884b4effa836551becae714b5ec.jpg",
        "img_caption": [
            "Fig.4In vitro and in vivo MR performance characterization.(a) Longitudinal $( r _ { 1 } )$ and transverse $( r _ { 2 } )$ MR relaxivity curves of FA-NPs and FA-NPs-PS nanocomposites; (b) $T _ { 1 } .$ and $T _ { 2 }$ -weighted MR imagesof FA-NPs,FA-NPs-PS nanocomposites and MCF-7and HeLacels incubated with FA-NPs and FA-NPs-PS nanocomposites,respectively; (c) and (d) $T _ { 2 }$ -weighted $M R$ images of MCF-7 tumor-bearing nude mice before and after injection of FA-NPs-PS. "
        ],
        "img_footnote": [],
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "3.4In vitro PDT performance ",
        "text_level": 1,
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "Under the irradiation of a $9 8 0 ~ \\mathrm { { n m } }$ laser, the in vitro PDT performance was assessed by the MTT assay and live/dead cell staining.Fig.5(a) and (b) show the viabilities of MCF-7 and HeLa cells in control experiments and incubated with NPs-PS and FA-NPs-PS on increasing the irradiation time from O to $1 0 ~ \\mathrm { { m i n } }$ .By FA targeting,a significant number of the incubated cells were killed,and the viabilities of MCF-7 and HeLa cells decreased to $1 8 . 4 \\%$ and $3 0 . 7 \\%$ ，respectively，compared with $2 5 . 7 \\%$ and $3 4 . 4 \\%$ on incubation with NPs-PS.Moreover,the viabilities of MCF-7 and HeLa cells in the control experiments only decreased to $9 3 . 9 \\%$ and $9 1 . 3 \\%$ ，respectively,indicating that a single $9 8 0 \\ \\mathrm { n m }$ laser has low photo-damage for cells. ",
        "page_idx": 4
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 4
    },
    {
        "type": "image",
        "img_path": "images/043f5a5f01df8ebdeef3a8124039020547d5e4d4c74faa99c130273a6759bebb.jpg",
        "img_caption": [
            "Fig.5IvitropforaneofCF-7ndHcelcbatedits-ndF-s-spectielyndaracterdy and live/dead cell staining under the irradiation of a $9 8 0 ~ \\mathsf { n m }$ laser with a power density of $0 . 5 \\mathrm { ~ W ~ c m } ^ { - 2 }$ ：(a)and (b) Viabilities of MCF-7 (a) and HeLa (b) cells in control experiments and incubated with $N P s \\mathrm { - } P S$ and FA-NPs-PS nanocomposites with the irradiation time of 0,1,4,7,and 10 min; (c) and (d)live/deadelaiiafF-7(nd)celitroexpritsdibaeditN-dF--t1 staining method under the irradiation of a $9 8 0 ~ \\mathsf { n m }$ laser with a power density of $0 . 5 ~ \\mathsf { W ~ c m } ^ { - 2 }$ and the irradiation time of $1 0 \\mathrm { \\ m i n }$ (the scale bar .s $2 0 0 ~ { \\mu \\mathrm { m } } )$ ： "
        ],
        "img_footnote": [],
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Fig.5(c) and (d) show the result of cell staining under different conditions,in which live/dead cells were labeled in green/red colors.Being consistent with that of the MTT assay，more MCF-7 and HeLa cells could be killed by incubating with FAtargeted NPs-PS.The in vitro PDT demonstrated that a significant number of the incubated cells could be killed using the combination of FA targeting and NIR irradiation. ",
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "3.5Cellular uptake and fluorescence tracing ",
        "text_level": 1,
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "The cellularuptake and targeted assessment of FA-NPs-PS in cells and in tumors were investigated by TEM and PS fluorescence imaging.Fig. 6(a)-(c) show fluorescence images of FA-NPs-PS nanocomposites and their incubation cellsat different concentrations.Compared with pure FA-NPs-PS nanocomposites,the PS fluorescence intensity in cells got weaker, which was attributed to the partial uptake of FA-NPs-PS nanocomposites by the cells.Moreover,the fluorescence intensity in MCF-7 cells was stronger than in HeLa cells,indicating a better targeting ability for MCF-7 cells.In addition,the cellular uptake of nanocomposites was also characterized by Bio-TEM. Fig.6(d) and (e) show TEM images of MCF-7 and HeLa cells incubated with FA-NPs-PS nanocomposites.Many nanocompo sites accumulated in vesicles,and the accumulation was more significant in MCF-7 cells,which is also consistent with the fluorescence images.Moreover，in order to quantitatively characterize the in vitro targeting ability of FA, the flow cytometerassay of MCF-7 cells and HeLa cells incubated with NPsPS and FA-NPs-PS nanocomposites was measured by detecting PS fluorescence,which indicated that the FA-NPs-PS nanocomposites greatly promoted the uptake of PS in both MCF-7 and HeLa cells (Fig. S4 and S5†). ",
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 5
    },
    {
        "type": "text",
        "text": "Furthermore,the targeting ability of FA in MCF-7 tumorbearing nudemicewas assessed through the intravenous injection of PBS,free PS,NPs-PS and FA-NPs-PS via the tail vein,by measuring the PS fluorescence intensity of the tumor and major organs(heart，liver，spleen，lung and kidney)in different mice.As shown in Fig. 6(f) and (g),by injecting NPsPSand FA-NPs-PS, the nanocomposites mainly accumulated in the liver and tumor due to the extra uptake of Kupffer cells in the liver and the enhanced permeation and retention (EPR) effect of nanomaterials in the tumor. Moreover,more nanocomposites were taken up by the tumor following injection with FA-NPs-PS,which could be attributed to FA targeting,as well as the EPR effect.Furthermore,in order to quantitatively investigate the in vivo targetingability of FA, the in vivo biodis tribution of FA-NPs-PS nanocomposites (in tumor,heart, liver, spleen, lung and kidney) via an intravenous injection was also measured,which indicated that FA-NPs-PS nanocomposites accumulate to a greater extent in the tumor,excluding the liver and spleen (Fig. S6†). ",
        "page_idx": 5
    },
    {
        "type": "image",
        "img_path": "images/3b4a3f4b44e51eacd39e5f6d96222f68d3124d3d0e50fcdf7018270c631a1cda.jpg",
        "img_caption": [
            "Fig.6CellartakedinidistributiofFA-aocopoitaractedbforesntimagid. rescentimagsfFA-N-(bo)andMF-7celincbateditA-NsS(top);(b)foreniagsofFA-N-(bomadHa cellsincubateithF-Ns;(fesetmasf-elot)dHcelcubedit-toie (d)and(e)celaptakesf-elnesebaedi-ssctively(f)aftuod ofMCF-7tumor-baringudeice;and(g)forescentimagesoftumrsandmajororgansofCF-7tumorbearingudemiceinectedithPB FA-NPs-PS, NPs-PS,and free PS via the tail vein. "
        ],
        "img_footnote": [],
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "3.6In vivo PDT performance ",
        "text_level": 1,
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "Byintratumorally injecting FA-NPs-PS nanocomposites，the volume change of MCF-7 tumors was traced by measuring the ",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "PS fluorescence over 15 day treatments.Fig. 7(a) and (b) show the fluorescence images of MCF-7 tumor-bearing nude mice in groups of FA-NPs-PS and FA-NPs-PS $^ +$ NIR，respectively.By injecting FA-NPs-PS nanocomposites，the PS fluo rescence intensity did not decrease over 15 days.However, under the irradiation of a $9 8 0 ~ \\mathrm { n m }$ laser,the PS fluorescence intensity gradually got weaker,and even disappeared,which indicated that the volume of the MCF-7 tumor got smaller; in addition, the photo-bleach of PS was also occurring during the process ofPDT. ",
        "page_idx": 6
    },
    {
        "type": "text",
        "text": "By modeling MCF-7 tumor-bearing nude mice,the in vivo PDT performance was assessed in all four groups of PBs,PBS $+ \\ \\mathrm { N I R } ,$ ,FA-NPs-PS and FA-NPs-PS $^ +$ NIR.Fig.8(a) and (b) show the change in relative tumor volume and body weight of MCF-7 tumor-bearing nude mice over 15 day treatments.On the final day,the relativevolume of the MCF-7 tumorswas 3.16,2.46,and 2.89 in groups of PBS,PBl $\\mathrm { { S + N I R } }$ ，FA-NPs-PS, but was only 0.16 in the group of FA-NPs-PS $^ +$ NIR.Moreover, the body weight in all four groups did not evidently decrease. Fig.8(c) gives the real images of MCF-7 tumor-bearing nude mice in all four groups at the beginning and at the end of the 15 day treatments,in which the tumor volume in the group of FA-NPs-PS $^ +$ NIR almost disappeared after the 15 day treatment.Furthermore,histological analysis of the tumors was also characterized.Fig.8(d) shows H&E staining images of the tumors in all four groups,in which many apoptotic and necrotic tumor cells appeared in the group of FA-NPs-PS $^ +$ NIR,but not nearly in other groups.The results demonstrated that MCF-7 tumors could be treated by NIR-triggered PDT of FA-NPs-PS nanocomposites. ",
        "page_idx": 6
    },
    {
        "type": "image",
        "img_path": "images/3f9f6292f626f9b75d32bd546422ccd0198ea68d3ca74e90d303e95162c408a5.jpg",
        "img_caption": [
            "Fig.7Invioforeemaigorreametof-umoaudemeiosofectingitraumoall-ad injecting intratumorally FA-NPs-PS $^ +$ PDT under the irradiation of a $9 8 0 ~ \\mathsf { n m }$ laser.(a) Fluorescent imaging of MCF-7 tumor-bearing nude mice injectedintratumolliA-b)fuesntiingfF-7toearieceectedntramoallit-d irradiated witha $9 8 0 ~ \\mathsf { n m }$ laser for PDT. "
        ],
        "img_footnote": [],
        "page_idx": 6
    },
    {
        "type": "image",
        "img_path": "images/e2c358aefaf60ace51e713cf365dae1203d0e5848633a834b6eabb8e227e02f9.jpg",
        "img_caption": [
            "Fig.8In vivo PDT characterization of MCF-7 tumor-bearing nude mice in different groups of PBS, $P B S + N I R ,$ FA-NPs-PS,and $F A - N P s - P S + N I R .$ (a)The change of relative tumor volume of MCF-7 tumor-bearing nude mice in different groups $( { } ^ { \\star } p < 0 . 0 5 ,$ $^ { \\star \\star } p < 0 . 0 1 )$ ; (b) the change of body weight of MCF-7 tumor-bearing nude mice in different groups; (c) the real photographs of MCF-7 tumor-bearing nude mice in different groups at the beginning and at the end of the 15 day treatments; and (d) H&E staining images of tumors in different groups (the scale bar is $5 0 ~ { \\mu \\ m } )$ ： "
        ],
        "img_footnote": [],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "In order to assess the effect of FA-NPs-PS nanocomposites and NIR irradiation on tumor treatment, the tissue sections of the major organs (heart, liver,spleen,lung,and kidney) of MCF-7 tumor-bearing nude mice in four groups were analyzed by H&E staining.As shown in Fig.9,in all four groups,the fibrosis in the heart and lung samples was not detected, the inflammatory reaction in the liver section was not found,and the glomerular and tubular structures in the kidney samples were also clearly displayed.Histological analysis of major organs revealed that pathological changes were not found in anyhistological specimens of all four groups.Therefore, these results demonstrate the safety and the potential clinical appli cation of FA-NPs-PS nanocomposites in MRI and NIR-triggered PDT of breast cancers. ",
        "page_idx": 7
    },
    {
        "type": "image",
        "img_path": "images/1a8cded0dc5f7695038157cb2b5384ea204a9a56c75f14c67770f5b6615825a8.jpg",
        "img_caption": [
            "Fig.9H&E staining images of major organs (heart, liver,spleen, lung, and kidney) of MCF-7 tumor-bearing nude mice in groups of PBS, ${ \\mathsf { P B S } } +$ NIR,FA-NPs-PS,and $F A - N P s - P S + N P R$ (the scale bar is $5 0 ~ { \\mu \\mathrm { m } } )$ · "
        ],
        "img_footnote": [],
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "4. Conclusions ",
        "text_level": 1,
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Insummary,FA-targeted,PS-loaded $\\mathrm { F e _ { 3 } O _ { 4 } @ N a Y F _ { 4 } { : } Y b / E 1 }$ nanocomposites were synthesized for in vivo $T _ { 2 }$ -weightedMRIand NIR-triggered PDT in deep-tissue tumors.The as-prepared FA-NPs-PS nanocomposites showed low cytotoxicity and good biocompatibility in vitro and in vivo.Moreover，the fluo rescence tracing of FA-NPs-PS nanocomposites in cells and in tumors demonstrated the effective targeting ability of FA in vitro and in vivo.Under the irradiation of a $9 8 0 ~ \\mathrm { n m }$ laser, the viabilities of MCF-7 and HeLa cells decreased to about $1 8 . 4 \\%$ and $3 0 . 7 \\%$ ,and the relative volume of the MCF-7 tumor decreased to about 0.16,which indicated an excellent NIR-triggered PDT performance.The MR measurement showed a transverse relaxivity value $\\left( r _ { 2 } \\right)$ of $ 3 . 7 9 \\ \\mathrm { \\ m M } ^ { - 1 } \\ \\mathrm { s } ^ { - 1 }$ ,and in vivo MR images demonstrated the application in $T _ { 2 }$ -weighted MR contrast agents.These results provide useful information about the reliability of FA targeting and in vivo MRI/PDT performance and will be important to the probable application of FA-NPs-PS nanocomposites in MRI diagnosis and visualized PDT of deep-tissue cancers later,including breast cancer. ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Acknowledgements ",
        "text_level": 1,
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "This work was supported by the National Natural Science Foundation of China (U1332117,51102251,and U1432114), theNational Key Basic Re-search Program of China (2014CB744504)， the Postdoctoral Science Foundationof China and Jiangsu Province, the Youth Innovation Promotion Association of Chinese Academy of Sciences (2015234),and the Hundred Talents Program of Chinese Academy of Sciences (WU A. G.). ",
        "page_idx": 7
    },
    {
        "type": "text",
        "text": "Notesand references ",
        "text_level": 1,
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "1 P. Huang,J. Lin,X. Wang,Z. Wang,C. Zhang,M. He, K.Wang,F. Chen, Z.Li,G. Shen,D. Cui and X. Chen,Adv. Mater.,2012,24,5104-5110.   \n2 B. Jang,J. Y. Park, C. H. Tung,I. H. Kim and Y. Choi, ACS Nano,2011,5,1086-1094. 3 J. Lin, S. Wang, P. Huang, Z. Wang, S. Chen, G. Niu, W. Li, J. He,D. Cui, G. Lu, X. Chen and Z. Nie,ACS Nano,2013,7, 5320-5329. 4 G.Gollavelli and Y. C.Ling, Biomaterials,2014,35,4499-4507. 5 D.Ling,W.Park,S.Park,Y. Lu,K.S.Kim,M.Hackett, B. H. Kim, H. Yim, Y. S. Jeon, K. Na and T. Hyeon, J. Am. Chem. Soc.,2014,136,5647-5655.   \n6 D. Wang, B.Fei, L. Halig,X. Qin, Z. Hu, H. Xu, Y. A. Wang, Z. Chen, S. Kim, D. Shin and Z. Chen,ACs Nano, 2014,8, 6620-6632.   \n7 Y.Ma, S. Tong,G.Bao,C. Gao and Z. Dai,Biomaterials, 2013,34, 7706-7714.   \n8 H. Gong, Z. Dong, Y. Liu, S. Yin, L. Cheng, W. Xi, J. Xiang, K.Liu, Y. Li and Z. Liu,Adv. Funct. Mater.,2014,24, 6492- 6502. 9 P. Huang, Z. Li, J. Lin,D. Yang,G. Gao,C. Xu,L. Bao, C. Zhang, K. Wang,H. Song,H. Hu and D. Cui, Biomaterials,2011,32,3447-3458.   \n10 M. Lin, Z. Li, Z. Liu, J. Ren, X. Yang and X. Qu, Chem. Commun.,2012,48,6556-6558.   \n11 X.Liang, X. Li, L. Jing, X. Yue and Z. Dai, Biomaterials, 2014,35,6379-6388.   \n12 Z. Li, C. Wang, L. Cheng,H. Gong, S. Yin, Q. Gong, Y. Li and Z.Liu,Biomaterials,2013,34, 9160-9170.   \n13 J. Shi,L. Wang, J. Gao,Y. Liu, J. Zhang,R. Ma, R. Liu and Z. Zhang,Biomaterials,2014,35,5771-5784.   \n14 L. Zeng,W. Ren, L. Xiang, J. Zheng, B. Chen and A. Wu, Nanoscale,2013,5,2107-2113.   \n15 J.V. Frangioni, Curr. Opin. Chem. Biol.,2003,7,626-634.   \n16 S.S. Lucky,N. M. Idris,Z.Li, K. Huang,K.C. Soo and Y. Zhang,ACS Nano,2015,9,191-205.   \n17R.Wang and F. Zhang,J. Mater. Chem. B,2014,2,2422-2443.   \n18 S.Cui, D. Yin, Y. Chen, Y. Di,H. Chen, Y. Ma, S.Achilefu and Y. Gu,ACS Nano,2013,7,676-688.   \n19 J.Y.Yhee,S.Lee and K. Kim,Nanoscale,2014,6,13383- 13390.   \n20 P. Huang, C. Xu, J. Lin,C. Wang, X. Wang,C. Zhang, X. Zhou, S. Guo and D. Cui, Theranostics, 2011,1, 240-250.   \n21 S.Cui,D.Yin,Y. Chen,Y.Di, H.Chen,Y.Ma, S.Achilefu and Y.Gu,ACS Nano,2013,7,676-688.   \n22 L. Xia, X. Kong, X. Liu, L. Tu, Y. Zhang, Y. Chang, K. Liu, D. Shen,H. Zhao and H. Zhang,Biomaterials,2014,35, 4146-4156.   \n23 D.Yang, X. Kang,P. Ma, Y. Dai, Z.Hou, Z. Cheng,C.Li and J. Lin,Biomaterials,2013,34,1601-1612.   \n24 C. Yang, Q. Liu, D. He,N. Na, Y. Zhao and J. Ouyang, Analyst,2014,139,6414-6420.   \n25 Y.Liu,D. Tu,H. Zhu and X.Chen,Chem. Soc. Rev.,2013, 42, 6924-6958.   \n26 J. Zhou, Q.Lu,W. Feng,Y. Sun and F.Li, Chem. Rev., 2015, 115, 395-465.   \n27 X.Li, D. Zhao and F. Zhang, Theranostics,2013,3,292-305.   \n28 C.Liu, Z. Gao,J. Zeng,Y. Hou,F.Fang, Y.Li,R.Qiao, L. Shen,H. Lei,W. Yang and M. Gao,ACS Nano,2013,7, 7227-7240.   \n29 F. Zhang,G. Braun,A. Pallaoro,Y. Zhang, Y. Zhang, D.Cui, M.Moskovits,D. Zhao and G. Stucky,Nano Lett.,2012,12, 61-67.   \n30 H. Zhu,J. Tao,W.Wang,Y. Zhou,P. Li, Z.Li,K. Yan, S.Wu,K. Yeung, Z. Xu,H. Xu and P. Chu, Biomaterials, 2013,34,2296-2306.   \n31 L.Cheng,K. Yang,Y.Li,X. Zeng,M. Shao,S.Lee and Z.Liu,Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy，Biomaterials，2012，33, 2215-2222.   \n32 L.Zeng,L. Xiang,W.Ren，J. Zheng,T. Li,B.Chen, J. Zhang,C. Mao,A. Li and A. Wu,RSC Adv.，2013，3, 13915-13925.   \n33 L. Zhang, L. Zeng, Y. Pan, S. Luo,W. Ren,A. Gong, X.Ma, H.Liang,G.Lu and A. Wu, Biomaterials,2015,44,82-90.   \n34 X. Qiao,J. Zhou, J. Xiao, Y. Wang,L. Sun and C. Yan, Nanoscale,2012,4,4611-4623.   \n35 Y.Zhang，G.Das，V.Vijayaragavan，Q.Xu, P.Padmanabhan,K. Bhakoo,S. Selvan and T. Tan,Nanoscale,2014,6,12609-12617.   \n36 F. Chen, S. Zhang,W. Bu, Y. Chen,Q. Xiao, J. Liu, H. Xing, L. Zhou,W. Peng and J. Shi,Chem. - Eur. J.,2012,18, 7082-7090.   \n37 Y.Park,H.M.Kim,J.H.Kim，K.C.Moon，B.Yo0, K.T.Lee，N.Lee,Y.Choi，W.Park,D. Ling，K.Na, W.K. Moon, S.H. Choi,H. S.Park, S.Y. Yoon, Y. D. Suh, S.H.Lee and T.Hyeon,Adv. Mater.,2012,24,5755-5761.   \n38 G.Liu, J. Gao,H. Ai and X. Chen,Small,2013,9,1533- 1545.   \n39 B. Liu, C. Li, P. Ma, Y. Chen, Y. Zhang, Z. Hou, S. Huang and J.Lin,Nanoscale,2015,7,1839-1848.   \n40 X. Zhu, J. Zhou,M. Chen,M. Shi,W. Feng and F. Li, Biomaterials,2012,33,4618-4627.   \n41 D.Hu, M. Chen, Y.Gao,F.Li and L.Wu,J. Mater. Chem., 2011,21,11276-11282.   \n42 C.Mi, J. Zhang,H. Gao,X. Wu, M.Wang,Y. Wu,Y. Di, Z. Xu, C. Mao and S. Xu, Nanoscale,2010,2,1141-1148. ",
        "page_idx": 8
    },
    {
        "type": "text",
        "text": "",
        "page_idx": 8
    }
]